Cowen Prime Advisors LLC Cytosorbents Corp Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
A detailed history of Cowen Prime Advisors LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 42,301 shares of CTSO stock, worth $37,647. This represents 0.05% of its overall portfolio holdings.
Number of Shares
42,301
Previous 46,050
8.14%
Holding current value
$37,647
Previous $113,000
33.63%
% of portfolio
0.05%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.7MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$2.65 Million0.45% of portfolio
-
Skylands Capital, LLC2.76MShares$2.45 Million0.6% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$1.86 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.74 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.59 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $38.8M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...